We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Novartis and Aurobindo have terminated their $1 billion deal to sell the Sandoz U.S. generic oral solids and dermatology business to Aurobindo. Read More
The company said that it suspended its exclusivity to enable a greater supply of the drug should additional trials or evaluations show it has potential in treating COVID-19. Read More
Biogen has filed suit against New York-based Creative Biolabs, claiming that the company has been copying its patented Alzheimer’s drug candidate aducanumab and selling imitation products to researchers online. Read More
Several drugmakers have committed to donating antimalaria treatments chloroquine and hydroxychloroquine after the Trump Administration showed interest in the drugs as potential COVID-19 treatments. Read More
Leaders of the House Energy and Commerce Committee asked FDA Commissioner Stephen Hahn how the agency intends to weigh priorities for the notification of shortages while protecting commercial information as the coronavirus continues to spread. Read More
Prescription drug prices increased by more than three times the rate of inflation between 2008 and 2017, according to a new analysis that accounts for rebates and discounts. Read More